<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 04 Apr 2026 00:13:24 -0400--><rss version="2.0">
    <channel>
        <title>Bio-Techne Corporation (TECH) SEC Filings</title>
        <link>https://investors.bio-techne.com/10k-filings/rss</link>
        <description>Bio-Techne Corporation (TECH) - 10-K Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_f0b975705403ab5250b3c1bdea3a82ff/biotechne/files/bio-techne-logo.png</url>
                <title>Bio-Techne Corporation Logo</title>
                <link>https://investors.bio-techne.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[ARS - Annual Report to Security Holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-4018-0001308179-25-000601</link>
                <pubDate>Fri, 19 Sep 25 07:07:40 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-4018-0001308179-25-000601</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[10 Related Documents: 10-K, EX-4.1, EX-19, EX-21, EX-23, EX-31.1, EX-31.2, EX-32.1, EX-32.2, EX-97]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-4001-0001558370-25-011716</link>
                <pubDate>Fri, 22 Aug 25 06:32:04 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-4001-0001558370-25-011716</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual report to security holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3922-0001308179-24-000705</link>
                <pubDate>Thu, 12 Sep 24 07:05:29 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3922-0001308179-24-000705</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[10 Related Documents: 10-K, EX-4.1, EX-19, EX-21, EX-23, EX-31.1, EX-31.2, EX-32.1, EX-32.2, EX-97]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3908-0001558370-24-012430</link>
                <pubDate>Thu, 22 Aug 24 16:32:10 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3908-0001558370-24-012430</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual report to security holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3827-0001308179-23-000979</link>
                <pubDate>Wed, 13 Sep 23 07:08:17 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3827-0001308179-23-000979</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-4.1, EX-19, EX-21.1, EX-23, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3794-0001558370-23-015226</link>
                <pubDate>Wed, 23 Aug 23 16:31:58 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3794-0001558370-23-015226</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.1, EX-21, EX-23, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3706-0001558370-22-013935</link>
                <pubDate>Wed, 24 Aug 22 16:32:49 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3706-0001558370-22-013935</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[17 Related Documents: 10-K, EX-4.1, EX-10.3, EX-10.4, EX-10.5, EX-10.6, EX-10.7, EX-10.8, EX-10.9, EX-10.10, EX-10.11, EX-21, EX-23, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3605-0001437749-21-020980</link>
                <pubDate>Wed, 25 Aug 21 16:48:07 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3605-0001437749-21-020980</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[17 Related Documents: 10-K, EX-4.1, EX-10.3, EX-10.4, EX-10.5, EX-10.6, EX-10.7, EX-10.8, EX-10.9, EX-10.10, EX-10.11, EX-21, EX-23, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3482-0001437749-20-018754</link>
                <pubDate>Wed, 26 Aug 20 16:38:16 -0400</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3482-0001437749-20-018754</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K/A - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 10-K/A, EX-23, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.bio-techne.com/10k-filings?page=1#document-3398-0001437749-19-021760</link>
                <pubDate>Wed, 06 Nov 19 16:48:23 -0500</pubDate>
                <guid isPermalink="true">https://investors.bio-techne.com/10k-filings?page=1#document-3398-0001437749-19-021760</guid>
                                                                            </item>
            </channel>
</rss>